From: Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients
Score of AE
Brolucizumab group
Aflibercept group
Total number of injections in all patients
262
354
Total number of AE reported
219
314
Score 1
195 (89.0%)
277 (88.2%)
Score 2
14 (6.4%)
35 (11.2%)
Score 3
9 (4.1%)
2 (0.64%)
Score 4
1 (0.46%)
0